The HinduLean L·
Will the price caps on cancer drugs help bring down the cost of treatment?
For cancer patients in India, the struggle to stay alive is as much about the disease as about the arithmetic of fighting it. Experts call the government’s price caps a tokenistic, short-term measure. Patients will not benefit unless structural changes including tackling pricing at the manufacturing end, and large-scale government procurement to stabilise prices are put in place Will capping trade margins on 137 non-scheduled anti-cancer drugs bring down the overall cost of treatment?
Read at The Hindu →
